Not applicableStudy completedNCT03452176What this trial is testingScrambler Trial for Pain in NMOSDWho this might be right forNeuromyelitis Optica Johns Hopkins University 22
Not applicableActive Not RecruitingNCT01623076What this trial is testingThe Longitudinal CONQUER Study of Rare Neuroimmunologic DisordersWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderTransverse Myelitis+1 more University of Texas Southwestern Medical Center 150
Not applicableLooking for participantsNCT06865274What this trial is testingFrequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.Who this might be right forNeuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05403138What this trial is testingSafety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum DisordersWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder Tianjin Medical University General Hospital 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07132398What this trial is testingSlow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSDWho this might be right forNeuromyelitis Optica (NMO)Neuromyelitis Optica Spectrum Disorders (NMOSD) Tianjin Medical University General Hospital 170
Not applicableNot Yet RecruitingNCT07704294What this trial is testingEarly Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic ToolWho this might be right forOptic NeuritisMultiple SclerosisNeuromyelitis Optica Spectrum Disorder+2 more King's College London 180
Large-scale testing (Phase 3)Study completedNCT04201262What this trial is testingAn Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSDWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 58
Not applicableLooking for participantsNCT05154370What this trial is testingChina National Registry of Neuro-Inflammatory DiseasesWho this might be right forMultiple SclerosisNMO Spectrum DisorderClinically Isolated Syndrome+4 more Beijing Tiantan Hospital 10,000
Not applicableLooking for participantsNCT06763848What this trial is testingProtein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis Optica Spectrum Disorders Third Affiliated Hospital, Sun Yat-Sen University 144
Not applicableLooking for participantsNCT07762872What this trial is testingProspective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDWho this might be right forNeuromyelitis Optica Spectrum Disorders (NMOSD) Junwei Hao, MD 50
Early research (Phase 1)Study completedNCT01777412What this trial is testingEfficacy of Bevacizumab (Avastin) in Treatment of Acute NMO ExacerbationsWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder Johns Hopkins University 10
Early research (Phase 1)Not Yet RecruitingNCT07573332What this trial is testingA Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsWho this might be right forAQP4+ NMOSD University of Texas Southwestern Medical Center 5
Very early researchNot Yet RecruitingNCT07592754What this trial is testingThe Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.Who this might be right forNeuromyelitis Optica Spectrum Disease (NMOSD) Chinese PLA General Hospital 18
Testing effectiveness (Phase 2)UnknownNCT06557174What this trial is testingEvaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) PatientsWho this might be right forNeuromyelitis Optica Spectrum Disorder (NMOSD) ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. 116
Testing effectiveness (Phase 2)UnknownNCT06497374What this trial is testingFcRn Antagonists (Efgartigimod) for Acute NMOSD AttackWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder Tianjin Medical University General Hospital 63
Testing effectiveness (Phase 2)UnknownNCT04064944What this trial is testingComparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum DisordersWho this might be right forNeuromyelitis Optica Spectrum Disorder Third Affiliated Hospital, Sun Yat-Sen University 144
Post-approval studies (Phase 4)Study completedNCT04256252What this trial is testingRituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)Who this might be right forNeuromyelitis Optica Spectrum Disorder Tang-Du Hospital 108
Not applicableLooking for participantsNCT06885957What this trial is testingMonoclonal Antibody-Based Therapies for AQP4-Positive NMOSDWho this might be right forNMO Spectrum Disorder Tongji Hospital 200
Not applicableEnrolling By InvitationNCT06374264What this trial is testingAcceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis Optica Spectrum Disorder MedRhythms, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT05909943What this trial is testingEfficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum DisordersWho this might be right forNeuromyelitis Optica Spectrum Disorder Relapse Tianjin Medical University General Hospital